A pharmaceutical formulation, comprising: a compound of formula (I), a tautomer of the compound, a salt of the compound, a salt of the tautomer, or a mixture thereof and at least one ingredient selected from the group consisting of (i) cellulose (ii) silicon dioxide (iii) magnesium stearate and (iv) an ingredient selected from crospovidone, starch, or lactose.
